166 CAST® Allergens available in our allergy product pipeline to date with continual development over the past several years.
- Products & Solutions
- FDA IVD
- About Us
- News & Events
- Contact
- Additional Sites
The history of BUHLMANN Cellular Allergy assays and relevant important studies, findings and publications.
166 CAST® Allergens available in our allergy product pipeline to date with continual development over the past several years.
The first publication for basophil activation: Sainte-Laudy J, Vallon C, Gu[1]erin JC.[Analysis of membrane expression of the CD63 human basophil activation marker. Applications to allergologic diagnosis]. Allerg Immunol (Leipz) 1994;26:211–214. (Independent of BÜHLMANN Laboratories AG)
The Discovery of CD63 activation marker: Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991;88:328–338. (Independent of BÜHLMANN Laboratories AG)
BUHLMANN Diagnostics Corp
105 Route 101A, Suite 1
Amherst, NH 03031
USA
(844) 300-9799
(603) 732-0675
info@buhlmannlabs.com